DexCom EBITDA Margin 2010-2025 | DXCM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DexCom (DXCM) over the last 10 years. The current EBITDA margin for DexCom as of June 30, 2025 is .
| DexCom EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $4.30B | $0.92B | 21.48% |
| 2025-03-31 | $4.15B | $0.86B | 20.68% |
| 2024-12-31 | $4.03B | $0.82B | 20.28% |
| 2024-09-30 | $3.95B | $0.84B | 21.24% |
| 2024-06-30 | $3.94B | $0.89B | 22.54% |
| 2024-03-31 | $3.80B | $0.85B | 22.33% |
| 2023-12-31 | $3.62B | $0.78B | 21.64% |
| 2023-09-30 | $3.40B | $0.68B | 19.89% |
| 2023-06-30 | $3.20B | $0.61B | 19.07% |
| 2023-03-31 | $3.02B | $0.56B | 18.49% |
| 2022-12-31 | $2.91B | $0.55B | 18.83% |
| 2022-09-30 | $2.79B | $0.42B | 15.00% |
| 2022-06-30 | $2.67B | $0.38B | 14.07% |
| 2022-03-31 | $2.57B | $0.38B | 14.77% |
| 2021-12-31 | $2.45B | $0.37B | 15.07% |
| 2021-09-30 | $2.32B | $0.46B | 19.84% |
| 2021-06-30 | $2.17B | $0.43B | 19.77% |
| 2021-03-31 | $2.03B | $0.39B | 19.09% |
| 2020-12-31 | $1.93B | $0.37B | 19.05% |
| 2020-09-30 | $1.82B | $0.36B | 19.71% |
| 2020-06-30 | $1.72B | $0.32B | 18.36% |
| 2020-03-31 | $1.60B | $0.24B | 15.19% |
| 2019-12-31 | $1.48B | $0.19B | 12.94% |
| 2019-09-30 | $1.35B | $-0.08B | -6.00% |
| 2019-06-30 | $1.22B | $-0.13B | -10.47% |
| 2019-03-31 | $1.13B | $-0.14B | -12.13% |
| 2018-12-31 | $1.03B | $-0.16B | -15.21% |
| 2018-09-30 | $0.92B | $0.02B | 1.64% |
| 2018-06-30 | $0.83B | $0.00B | -0.36% |
| 2018-03-31 | $0.76B | $-0.02B | -1.97% |
| 2017-12-31 | $0.72B | $-0.03B | -3.76% |
| 2017-09-30 | $0.67B | $-0.05B | -6.88% |
| 2017-06-30 | $0.63B | $-0.06B | -10.11% |
| 2017-03-31 | $0.60B | $-0.07B | -11.69% |
| 2016-12-31 | $0.57B | $-0.05B | -8.55% |
| 2016-09-30 | $0.53B | $-0.04B | -7.88% |
| 2016-06-30 | $0.49B | $-0.07B | -13.91% |
| 2016-03-31 | $0.45B | $-0.05B | -11.91% |
| 2015-12-31 | $0.40B | $-0.05B | -11.69% |
| 2015-09-30 | $0.36B | $-0.05B | -13.24% |
| 2015-06-30 | $0.32B | $-0.01B | -3.13% |
| 2015-03-31 | $0.29B | $-0.01B | -4.56% |
| 2014-12-31 | $0.26B | $-0.01B | -5.02% |
| 2014-09-30 | $0.23B | $-0.02B | -7.49% |
| 2014-06-30 | $0.20B | $-0.02B | -8.96% |
| 2014-03-31 | $0.18B | $-0.02B | -12.36% |
| 2013-12-31 | $0.16B | $-0.02B | -13.04% |
| 2013-09-30 | $0.14B | $-0.03B | -19.01% |
| 2013-06-30 | $0.12B | $-0.04B | -31.15% |
| 2013-03-31 | $0.11B | $-0.04B | -39.45% |
| 2012-12-31 | $0.10B | $-0.05B | -48.48% |
| 2012-09-30 | $0.09B | $-0.05B | -60.23% |
| 2012-06-30 | $0.08B | $-0.05B | -60.24% |
| 2012-03-31 | $0.08B | $-0.04B | -53.09% |
| 2011-12-31 | $0.08B | $-0.04B | -53.33% |
| 2011-09-30 | $0.07B | $-0.04B | -55.07% |
| 2011-06-30 | $0.06B | $-0.04B | -60.32% |
| 2011-03-31 | $0.05B | $-0.04B | -77.78% |
| 2010-12-31 | $0.05B | $-0.04B | -82.00% |
| 2010-09-30 | $0.04B | $-0.04B | -93.18% |
| 2010-06-30 | $0.04B | $-0.04B | -102.56% |
| 2010-03-31 | $0.03B | $-0.04B | -123.53% |
| 2009-12-31 | $0.03B | $-0.04B | -144.83% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $29.788B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $185.313B | 22.42 |
| Intuitive Surgical (ISRG) | United States | $167.925B | 69.61 |
| IDEXX Laboratories (IDXX) | United States | $51.311B | 53.40 |
| Edwards Lifesciences (EW) | United States | $47.473B | 31.46 |
| Alcon (ALC) | Switzerland | $39.834B | 26.74 |
| IQVIA Holdings (IQV) | United States | $31.963B | 18.06 |
| Mettler-Toledo (MTD) | United States | $26.568B | 31.53 |
| STERIS (STE) | Ireland | $24.473B | 26.05 |
| Waters (WAT) | United States | $17.795B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.026B | 0.00 |
| Hologic (HOLX) | United States | $14.931B | 16.18 |
| Penumbra (PEN) | United States | $10.302B | 75.26 |
| Globus Medical (GMED) | United States | $8.290B | 19.12 |
| Sysmex ADR (SSMXY) | Japan | $8.139B | 25.86 |
| Masimo (MASI) | United States | $7.885B | 26.54 |
| Teleflex (TFX) | United States | $5.637B | 9.10 |
| Glaukos (GKOS) | United States | $5.250B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.57 |
| Integer Holdings (ITGR) | United States | $3.811B | 19.02 |
| LivaNova (LIVN) | United Kingdom | $3.077B | 17.61 |
| Alphatec Holdings (ATEC) | United States | $2.344B | 0.00 |
| Veracyte (VCYT) | United States | $2.325B | 32.12 |
| PROCEPT BioRobotics (PRCT) | United States | $2.187B | 0.00 |
| Artivion (AORT) | United States | $2.056B | 103.74 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.866B | 17.46 |
| Integra LifeSciences Holdings (IART) | United States | $1.112B | 6.37 |
| Pulse Biosciences (PLSE) | United States | $1.109B | 0.00 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.909B | 44.14 |
| Tandem Diabetes Care (TNDM) | United States | $0.818B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.692B | 0.00 |
| AxoGen (AXGN) | United States | $0.681B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.538B | 9.51 |
| OrthoPediatrics (KIDS) | United States | $0.509B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.472B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.444B | 3.57 |
| Pacific Biosciences Of California (PACB) | United States | $0.396B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.08 |
| AngioDynamics (ANGO) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.75 |
| RxSight (RXST) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.290B | 20.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.272B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.219B | 0.00 |
| Neuronetics (STIM) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.133B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| InspireMD (NSPR) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.085B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.38 |